A. Hussein

发表

Activity of pirarubicin (4′‐o‐tetrahydropyranyladriamycin) in malignant mesothelioma

L. Feun, K. Sridhar, M. Patricia, 1989, Cancer.

Evolving role of surgical treatment in limited‐disease small cell lung carcinoma

R. Thurer, K. Sridhar, A. Hussein, 1989, Journal of surgical oncology.

Genomic Landscape of Angiosarcoma: A Targeted and Immunotherapy Biomarker Analysis

M. Oberley, M. von Mehren, A. Rosenberg, 2020, Cancers.

Reduced mortality following bone marrow transplantation for breast cancer with the addition of peripheral blood progenitor cells is due to a marked reduction in veno-occlusive disease of the liver

D. Berry, W. Petros, J. Vredenburgh, 1998, Bone Marrow Transplantation.

Tumor Lysis Syndrome After Induction Chemotherapy in Small‐Cell Lung Carcinoma

L. Feun, A. Hussein, 1990, American journal of clinical oncology.

Phase II trial of 4′‐O‐tetrahydropyranyladriamycin (pirarubicin) in head and neck carcinoma

N. Savaraj, K. Sridhar, S. Richman, 1992, Cancer.

Evaluation of GM-CSF mouthwash for prevention of chemotherapy-induced mucositis: a randomized, double-blind, dose-ranging study.

G. Rosner, L. Cartee, W. Petros, 1995, Cytokine.

A randomized trial of recombinant human interleukin-11 following autologous bone marrow transplantation with peripheral blood progenitor cell support in patients with breast cancer.

J. Vredenburgh, J. Loewy, K. Dykstra, 1998, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Effects of granulocyte-macrophage colony stimulating factor produced in Chinese hamster ovary cells (regramostim), Escherichia coli (molgramostim) and yeast (sargramostim) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy.

J. Kurtzberg, V. Hárs, W. Petros, 1995, European journal of haematology.

The addition of paclitaxel to continuous infusion 5-fluorouracil is an active regimen for metastatic breast cancer.

W. Petros, J. Vredenburgh, M. Ross, 1998, American journal of clinical oncology.

Thrombotic microangiopathic syndromes after bone marrow transplantation.

J. Byrnes, A. Hussein, 1996, Cancer investigation.

Chemotherapy with cisplatin and 5‐fluorouracil for penile and urethral squamous cell carcinomas

K. Sridhar, P. Benedetto, A. Hussein, 1990, Cancer.

Thrombotic microangiopathy as a complication of high-dose chemotherapy for breast cancer.

W. Petros, J. Vredenburgh, M. Ross, 1996, Bone marrow transplantation.

Impact of consolidation radiotherapy in patients with advanced breast cancer treated with high-dose chemotherapy and autologous bone marrow rescue.

L. Marks, L. Prosnitz, G. Broadwater, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Five-drug antiemetic combination for cisplatin chemotherapy.

S. Hilsenbeck, V. Cairns, K. Sridhar, 1992, Cancer investigation.

Role of cytokines in autologous bone marrow transplantation.

J. Kurtzberg, W. Petros, J. Vredenburgh, 1993, Hematology/oncology clinics of North America.

Combination Chemotherapy and Radiotherapy for Small‐Cell Carcinoma of the Esophagus: A Case Report of Long‐Term Survival and Review of the Literature

L. Feun, K. Sridhar, S. Waldman, 1990, American journal of clinical oncology.

Synergism of ara-C-imuvert combination in aborting the development of transplanted chloroleukemia in the rat.

J. Jimenez, A. Yunis, M. Hindahl, 1991, The American journal of the medical sciences.

Pharmacokinetic interaction between ondansetron and cyclophosphamide during high-dose chemotherapy for breast cancer

D. Berry, C. Mckinstry, W. Petros, 1998, Cancer Chemotherapy and Pharmacology.

A radiologic syndrome after high dose chemotherapy and autologous bone marrow transplantation, with clinical and pathologic features of systemic candidiasis

E. Paulson, J. Vredenburgh, M. Ross, 1994, Cancer.

Small cell carcinoma of the stomach

A. Hussein, C. Otrakji, Bernardina T. Hussein, 1990, Digestive Diseases and Sciences.

Carcinomatous meningitis from transitional cell carcinoma of the bladder: Case report

N. Savaraj, L. Feun, A. Hussein, 1989, Journal of Neuro-Oncology.

Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow support.

J. Perfect, J. Vredenburgh, M. Ross, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I trial of recombinant human interleukin-1β(OCT-43) following high-dose chemotherapy and autologous bone marrow transplantation

J. Kurtzberg, M. Crump, M. Ross, 1997, Bone Marrow Transplantation.

A phase I/II study of high-dose cyclophosphamide, cisplatin, and thioTEPA followed by autologous bone marrow and granulocyte colony-stimulating factor-primed peripheral-blood progenitor cells in patients with advanced malignancies

D. Berry, A. Berchuck, E. Shpall, 1996, Cancer Chemotherapy and Pharmacology.

Carbetimer: a re-evaluation of a drug with a novel mechanism of action.

M. Shields, B. Ardalan, W. Shanahan, 1991, Cancer treatment reviews.

Carbetimer:are-evaluationofadrugwitha novelmechanismofaction

M. Shields, B. Ardalan, W. Shanahan, 1991 .

Consolidation with high-dose combination alkylating agents with bone marrow transplantation significantly improves disease-free survival in hormone-insensitive metastatic breast cancer in complete remission compared with intensive standard-dose chemotherapy alone.

L. Marks, E. Shpall, G. Broadwater, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hypercalcemia in Head and Neck Squamous‐Cell Carcinoma

K. Sridhar, A. Hussein, 1990, American journal of clinical oncology.

Effects of granulocyte‐macrophage colony stimulating factor produced in Chinese hamster ovary cells (regramostim), Escherichia coli (molgramostim) and yeast (sargramostim) on priming peripheral blood progenitor cells for use with autologous Done marrow after high‐dose chemotherapy

J. Kurtzberg, V. Hárs, J. Vredenburgh, 1995, European journal of haematology.

PROTECTION AGAINST CYTOSINE ARABINOSIDE‐INDUCED ALOPECIA BY MINOXIDIL IN A RAT ANIMAL MODEL

A. Hussein, A. M. Hussein, 1995, International journal of dermatology.

Interleukin 1 protects against 1-beta-D-arabinofuranosylcytosine-induced alopecia in the newborn rat animal model.

A. Hussein, 1991, Cancer research.

The use of intensive clinic support to permit outpatient autologous bone marrow transplantation for breast cancer.

J. Vredenburgh, M. Ross, W. Peters, 1994, Seminars in oncology.

Protection from chemotherapy-induced alopecia in a rat model.

J. Jimenez, A. Yunis, C. McCall, 1990, Science.

Guillain‐Barre Syndrome Following Autologous Bone Marrow Transplantation

W. Peters, A. Hussein, Raja Mudad, 1995, American journal of clinical oncology.

High-dose chemotherapy and hematopoietic support for patients with high-risk primary breast cancer and involvement of 4 to 9 lymph nodes.

L. Marks, G. Broadwater, D. Rizzieri, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prognostic a nd P redictive F actors f or P atients W ith Metastatic B reast C ancer U ndergoing A ggressive I nduction Therapy F ollowed b y H igh-Dose C hemotherapy W ith Autologous S tem-Cell S upport

D. Berry, G. Broadwater, M. Ross, 2013 .

Prognostic and predictive factors for patients with metastatic breast cancer undergoing aggressive induction therapy followed by high-dose chemotherapy with autologous stem-cell support.

D. Berry, E. Shpall, G. Broadwater, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chemotherapy-Induced Alopecia: New Developments

A. Hussein, 1993, Southern medical journal.

Small cell carcinoma of the large intestine presenting as central nervous systems signs and symptoms. Two case reports with literature review

L. Feun, K. Sridhar, P. Benedetto, 1990, Journal of Neuro-Oncology.

Phase II trial of 4'-0-tetrahydropyranyladriamycin (pirarubicin) in head and neck carcinoma.

N. Savaraj, K. Sridhar, S. Richman, 1992, Cancer.

Prevention of hemorrhagic cystitis after high-dose alkylating agent chemotherapy and autologous bone marrow support.

J. Vredenburgh, M. Ross, B. Meisenberg, 1994, Bone marrow transplantation.